A detailed history of Natixis Advisors, L.P. transactions in Bio Techne Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 169,681 shares of TECH stock, worth $10.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
169,681
Previous 158,056 7.35%
Holding current value
$10.5 Million
Previous $12.6 Million 3.25%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$66.37 - $78.17 $771,551 - $908,726
11,625 Added 7.35%
169,681 $12.2 Million
Q3 2024

Nov 06, 2024

BUY
$70.96 - $82.35 $1.16 Million - $1.34 Million
16,328 Added 11.52%
158,056 $12.6 Million
Q2 2024

Aug 01, 2024

SELL
$62.12 - $84.15 $6.91 Million - $9.36 Million
-111,240 Reduced 43.97%
141,728 $10.2 Million
Q1 2024

Apr 25, 2024

SELL
$65.98 - $77.09 $2.06 Million - $2.41 Million
-31,224 Reduced 10.99%
252,968 $17.8 Million
Q4 2023

Feb 06, 2024

BUY
$52.83 - $78.22 $3.31 Million - $4.9 Million
62,632 Added 28.27%
284,192 $21.9 Million
Q3 2023

Nov 13, 2023

SELL
$67.52 - $89.42 $2.88 Million - $3.82 Million
-42,723 Reduced 16.17%
221,560 $15.1 Million
Q2 2023

Aug 15, 2023

BUY
$73.76 - $85.98 $2.21 Million - $2.58 Million
30,008 Added 12.81%
264,283 $21.6 Million
Q1 2023

May 11, 2023

BUY
$71.62 - $86.62 $152,478 - $184,413
2,129 Added 0.92%
234,275 $17.4 Million
Q4 2022

Jan 27, 2023

BUY
$80.67 - $352.29 $15.4 Million - $67.4 Million
191,238 Added 467.48%
232,146 $19.2 Million
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $389,905 - $540,753
1,380 Added 3.49%
40,908 $11.6 Million
Q2 2022

Aug 12, 2022

BUY
$322.67 - $449.65 $315,571 - $439,757
978 Added 2.54%
39,528 $13.7 Million
Q1 2022

May 12, 2022

BUY
$353.85 - $487.79 $3.69 Million - $5.09 Million
10,442 Added 37.15%
38,550 $16.7 Million
Q4 2021

Feb 08, 2022

BUY
$456.15 - $525.06 $38,316 - $44,105
84 Added 0.3%
28,108 $14.5 Million
Q3 2021

Nov 15, 2021

BUY
$444.87 - $538.88 $302,511 - $366,438
680 Added 2.49%
28,024 $13.6 Million
Q2 2021

Aug 12, 2021

SELL
$387.35 - $450.26 $216,916 - $252,145
-560 Reduced 2.01%
27,344 $12.3 Million
Q1 2021

May 05, 2021

SELL
$314.62 - $411.0 $152,905 - $199,746
-486 Reduced 1.71%
27,904 $10.7 Million
Q4 2020

Feb 12, 2021

BUY
$246.9 - $321.87 $1.31 Million - $1.7 Million
5,293 Added 22.92%
28,390 $9.02 Million
Q3 2020

Nov 12, 2020

SELL
$232.22 - $282.96 $444,469 - $541,585
-1,914 Reduced 7.65%
23,097 $5.72 Million
Q2 2020

Aug 11, 2020

BUY
$185.43 - $279.56 $2.23 Million - $3.37 Million
12,049 Added 92.96%
25,011 $6.61 Million
Q1 2020

Apr 27, 2020

SELL
$161.17 - $221.51 $17,245 - $23,701
-107 Reduced 0.82%
12,962 $2.46 Million
Q4 2019

Feb 10, 2020

BUY
$189.68 - $222.09 $546,278 - $639,619
2,880 Added 28.27%
13,069 $2.87 Million
Q3 2019

Nov 12, 2019

BUY
$183.56 - $216.72 $1.87 Million - $2.21 Million
10,189 New
10,189 $1.99 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.42B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.